Decreased Ecto-Ntpdase1/Cd39 Activity Leads to Desensitization of P2 Purinoceptors Regulating Tonus of Corpora Cavernosa in Impotent Men with Endothelial Dysfunction

REFERENCES

• Tong , Y. C. , Broderick , G. A. , Hypolite , J. A. and Levin , R. M. 1992 . Correlations of purinergic, cholinergic and adrenergic functions in rabbit corporal cavernosal tissue . Pharmacology , 45 : 241 – 249 .
   PubMed Web of Science ®Google Scholar
• Faria , M. , Magalhães-Cardoso , T. , Lafuente-de-Carvalho , J.-M. and Correia-de-Sá , P. 2006 . Corpus cavernosum from men with vasculogenic impotence is partially resistant to adenosine relaxation due to endothelial A2B receptor dysfunction . J. Pharmacol. Exper. Therapeut. , 319 : 405 – 413 .
   PubMed Web of Science ®Google Scholar
• Zimmermann , H. , Beaudoin , A. R. , Bollen , M. , Goding , J. W. , Guidotti , G. , Kirley , T. L. , Robson , S. C. and Sano , K. . Proposed nomenclature for two novel nucleotide hydrolyzing enzyme families expressed on the cell surface . Ecto-ATPases and Related Ectonucleotidases Proceedings of the Second International Workshop on Ecto-ATPases and Related Ectonucleotidases . Edited by: Vanduffel , L. and Lemmens , R. pp. 1 – 8 . Maastricht, , The Netherlands : Shaker Publishing .
   Google Scholar
• Zimmermann , H. 1992 . 5′-Nucleotidase: Molecular structure and functional aspects . Biochem. J. , 285 : 345 – 365 .
   PubMed Web of Science ®Google Scholar
• Marcus , A. J. , Broekman , M. J. , Drosopoulos , J. H. F. , Islam , N. , Alyonycheva , T. N. , Safier , L. B. , Hajjar , K. A. , Posnett , D. N. , Schoenborn , M. A. , Schooley , K. A. , Gayle , R. B. and Maliszewski , C. R. 1997 . The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39 . J. Clin. Invest. , 99 : 1351 – 1360 .
   PubMed Web of Science ®Google Scholar
• Thompson , I. M. , Tangen , C. M. , Goodman , P. J. , Probstfield , J. L. , Moinpour , C. M. and Coltman , C. A. 2005 . Erectile dysfunction and subsequent cardiovascular disease . JAMA , 294 : 2996 – 3002 .
   PubMed Web of Science ®Google Scholar
• Kaczmarek , E. , Koziak , K. , Sévigny , J. , Siege , L. J. B. , Anrather , J. , Beaudoin , A. R. , Bach , F. H. and Robson , S. C. 1996 . Identification and characterization of CD39/vascular ATP diphosphohydrolase . J. Biol. Chem. , 271 : 33116 – 33122 .
   PubMed Web of Science ®Google Scholar
• Magalhães-Cardoso , M. T. , Pereira , M. F. , Oliveira , L. , Ribeiro , J. A. , Cunha , R. A. and Correia-de-Sá , P. 2003 . Ecto-AMP deaminase blunts the ATP-derived adenosine A2A receptor facilitation of acetylcholine release at rat motor nerve endings . J. Physiol. (Lond.) , 549 : 399 – 408 .
   Google Scholar
• Robson , S. C. , Sévigny , J. and Zimmermann , H. 2006 . The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance . Purinergic Signal. , 2 : 409 – 430 .
   PubMedGoogle Scholar
• Enjyoji , K. , Sévigny , J. , Lin , Y. , Frenette , P. S. , Christie , P. D. , Esch , J. S. II , Imai , M. , Edelberg , J. M. , Rayburn , H. , Lech , M. , Beeler , D. L. , Csizmadia , E. , Wagner , D. D. , Robson , S. C. and Rosenberg , R. D. 1999 . Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation . Nat. Med. , 5 : 1010 – 1017 .
   PubMed Web of Science ®Google Scholar
• Dwyer , K. M. , Robson , S. C. , Nandurkar , H. H. , Campbell , D. J. , Gock , H. , Murray-Segal , L. J. , Fisicaro , N. , Mysore , T. B. , Kaczmarek , E. , Cowan , P. J. and d'Apice , A. J. F. 2004 . Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation . J. Clin. Invest. , 113 : 1440 – 1446 .
   PubMed Web of Science ®Google Scholar
• Goepfert , C. , Sundberg , C. , Sévigny , J. , Enjyoji , K. , Hoshi , T. , Csizmadia , E. and Robson , S. 2001 . Disordered cellular migration and angiogenesis in cd39-null mice . Circulation , 104 : 3109 – 3115 .
   PubMed Web of Science ®Google Scholar
• Mizumoto , N. , Kumamoto , T. , Robson , S. C. , Sévigny , J. , Matsue , H. , Enjyoji , K. and Takashima , A. 2002 . CD39 is the dominant Langerhans cell–associated ecto-NTPDase: Modulatory roles in inflammation and immune responsiveness . Nat. Med. , 8 : 358 – 365 .
   PubMed Web of Science ®Google Scholar
• Kunapuli , S. P. and Daniel , J. L. 1998 . P2 receptor subtypes in the cardiovascular system . Biochem. J. , 336 : 513 – 523 .
   PubMed Web of Science ®Google Scholar
• Ray , F. R. , Huang , W. , Slater , M. and Barden , J. A. 2002 . Purinergic receptor distribution in endothelial cells in blood vessels: a basis for selection of coronary artery grafts . Atherosclerosis. , 162 : 55 – 61 .
   PubMed Web of Science ®Google Scholar
• Harrington , L. S. and Mitchell , J. A. 2004 . Novel role for P2X receptor activation in endothelium-dependent vasodilation . Br. J. Pharmacol. , 143 : 611 – 617 .
   PubMed Web of Science ®Google Scholar
• Ralevic , V. and Burnstock , G. 1998 . Receptors for purines and pyrimidines . Pharmacol. Rev. , 50 : 413 – 492 .
   PubMed Web of Science ®Google Scholar
• Burnstock , G. 2007 . Purine and pyrimidine receptors . Cell. Mol. Life Sci. , 64 : 1471 – 1483 .
   PubMed Web of Science ®Google Scholar
• Rettinger , J. and Schmalzing , G. 2003 . Activation and desensitization of the recombinant P2X1 receptor at nanomolar ATP concentrations . J. Gen. Physiol. , 121 : 451 – 461 .
   PubMed Web of Science ®Google Scholar
• Wilkinson , G. F. , Purkiss , J. R. and Boarder , M. R. 1994 . Differential heterologous and homologous desensitization of two receptors for ATP (P2Y receptors and nucleotide receptors) coexisting on endothelial cells . Mol. Pharmacol. , 45 : 731 – 736 .
   PubMed Web of Science ®Google Scholar